P2RY12 and diabetes mellitus: Instead, antiplatelet drugs provide a fundamental pharmacological strategy in secondary CV prevention in diabetes by utilizing aspirin or a P2Y12 inhibitor or a combination of two drugs, depending on the clinical context, taking into account that the superior efficacy of more potent antithrombotic approaches most often occurs at the expense of increased bleeding [168].